The Corporation of Mercer University

Cybin Irl Limited

Clinton E Canal

Alex Nivorozhkin

Michael Palfreyman

Joshua A Hartsel

Brett J Greene

Alex Belser

Nader Moniri

Yiming Chen

There are disclosed deuterated 2C—X phenethylamine compounds, the use of such compounds in the treatment of diseases associated with a serotonin 5-HTreceptor, pharmaceutical compositions such as tablet compositions and kits containing the compounds, methods of delivering the compounds in a mist via inhalation, and methods of treating diseases or disorders associated with a serotonin 5-HTreceptor, such as central nervous system (CNS) disorders or psychological disorders with the compounds of the invention.

Therapeutic phenethylamine compositions and methods of use

Compounds, such as cathinone derivatives, and pharmaceutical formulations that include the compounds. The compounds may have a first selectivity for a first receptor subtype that is at least 10 times greater than a second selectivity for a second receptor subtype from the same class of receptors. Methods of treating patients, which may include administering to a patient a pharmaceutical formulation that includes a compound, such as a cathinone derivative.

Cathinone derivatives, pharmaceutical formulations, and methods

Growing community of inventors

ATLANTA, GA, United States of America

Clinton E Canal